Compositions and methods modulating MG29 for the treatment of diabetes

Details for Australian Patent Application No. 2010254820 (hide)

Owner University of Medicine and Dentistry of New Jersey

Inventors Lin, Peihui; Ma, Jianjie; Weisleder, Noah; Zhu, Hua

Agent Shelston IP

Pub. Number AU-A-2010254820

PCT Pub. Number WO2010/141810

Priority 61/217,926 05.06.09 US

Filing date 4 June 2010

Wipo publication date 9 December 2010

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/141810 Priority application(s): WO2010/141810

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010254830-Heat and/or steam activated valve and method therefor

2010254817-Nacelle configurations for a shrouded wind turbine